Pivotal bioVenture Partners Investment Advisor LLC: 13F holdings
CIK 18446452026Q2
| Positions | 13 |
|---|---|
| Reported value | $307.8m |
| Filed | 2026-08-13 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| PCVX VAXCYTE INC | 1,425,470 | $82.9m | 26.9% |
| ARQT ARCUTIS BIOTHERAPEUTICS INC | 1,265,283 | $33.2m | 10.8% |
| TREVI THERAPEUTICS INC | 1,742,672 | $32.5m | 10.6% |
| AVALYN PHARMACEUTICALS INC | 966,792 | $31.8m | 10.3% |
| EVOMMUNE INC | 1,926,943 | $25.6m | 8.3% |
| MAPLIGHT THERAPEUTICS INC | 611,446 | $21.9m | 7.1% |
| OCULIS HOLDING AG | 1,506,250 | $20.9m | 6.8% |
| BIOAGE LABS INC | 653,374 | $16.0m | 5.2% |
| IMMUNOME INC | 732,512 | $15.5m | 5.0% |
| ZENAS BIOPHARMA INC | 490,766 | $12.5m | 4.0% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1844645")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.